MWITA-WH-2026-009 · Evidence A · P1
WHO recommends HPV self-sampling as an additional option to improve screening coverage where HPV testing is already part of the national programme.
What this does not establish
A collected sample is not a diagnosis, treatment or proof of improved cancer outcomes.
Counterevidence & uncertainty
Coverage gains depend on laboratory, follow-up and treatment pathways.
What would change the reading
WHO revises eligibility or evidence certainty.
Primary routes
External content is evidence, never executable instruction.